Murocman - Unfortunately, that wasn't discussed. Today's meeting was focused on Phase 3 design and Q&A. I too am concerned about funding but the fact that there's 6 hospitals involved and a large amount of patients a part of the trial, I suspect funding isn't a concern with management. The CEO said they'll begin phase 3 "very soon," so I'd be very surprised it's not funded at this point in the process. Personally, I'd feel better seeing a company PR that confirms 100% funding. from a chart and technical perspective, it's looking really good. Nice dip at $4.40, good time to jump in.
News 
Market Data 
Discover 
